Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma

Robert J. Motzer, Carlos H. Barrios, Tae Min Kim, Silvia Falcon, Thomas Cosgriff, W. Graydon Harker, Vichien Srimuninnimit, Ken Pittman, Roberto Sabbatini, Sun Young Rha, Thomas W. Flaig, Ray Page, Sevil Bavbek, J. Thaddeus Beck, Poulam Patel, Foon Yiu Cheung, Sunil Yadav, Edward M. Schiff, Xufang Wang, Julie NiolatDalila Sellami, Oezlem Anak, Jennifer J. Knox

Research output: Contribution to journalArticlepeer-review

239 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences